Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematocrit and bleeding time: an update

A Anand1, S E Feffer

  • 1Nassau County Medical Center, East Meadow, NY.

Southern Medical Journal
|March 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethical and legal challenges of integrating artificial intelligence into paediatric surgery.

Annals of the Royal College of Surgeons of England·2026
Same author

Knowledge, awareness and practices regarding human papillomavirus vaccine amongst secondary school girls and mothers in North India.

European journal of obstetrics, gynecology, and reproductive biology·2026
Same author

Maternal risk factors and closure techniques in gastroschisis: a 16-year retrospective review from a UK tertiary centre.

Pediatric surgery international·2025
Same author

From expectations to experiences: a systematic review of patient and public perspectives on robotic surgery.

Journal of robotic surgery·2025
Same author

Talk smart, treat better.

British dental journal·2025
Same author

Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial.

European journal of cancer (Oxford, England : 1990)·2025
Same journal

SMA's 6th Annual Physicians-in-Training Leadership Conference Abstract Presentations.

Southern medical journal·2026
Same journal

Potential Impact of Lower Federal Loan Availability on Medical Education in Appalachia.

Southern medical journal·2026
Same journal

Experiential Mentorship Skills Training: The Effect on Real-Life Mentoring.

Southern medical journal·2026
Same journal

Social Pressure: How Early Social Context Shapes Career Interest in Medicine.

Southern medical journal·2026
Same journal

Comparing Speed and Accuracy of Artificial Intelligence Large Language Models on the Orthopedic In-Training Examination.

Southern medical journal·2026
Same journal

Don't Wait to Talk about Weight: A 2-Hour Interactive Curriculum Improves Medical Student Skills with Weight Management.

Southern medical journal·2026
See all related articles

Anemia prolongs bleeding time, even with normal platelet counts. Improving hematocrit levels, through transfusions or erythropoietin, shortens bleeding time in anemic patients.

Area of Science:

  • Hematology
  • Vascular Biology
  • Nephrology

Background:

  • Anemia is associated with prolonged bleeding time, independent of platelet count.
  • Platelet dysfunction in uremia is multifactorial, with anemia being a significant contributor.
  • Elevating hematocrit levels can shorten bleeding time.

Purpose of the Study:

  • To investigate the relationship between hematocrit and bleeding time in anemic patients.
  • To explore the efficacy of interventions targeting anemia in improving hemostasis.
  • To highlight the clinical relevance of hematocrit in bleeding tendencies.

Main Methods:

  • Observational analysis of bleeding time in anemic patients.
  • Assessment of bleeding time changes following red blood cell transfusions.

Related Experiment Videos

  • Evaluation of recombinant human erythropoietin's effect on bleeding time and hematocrit.

    • Main Results:

    • Bleeding time is prolonged in anemic patients and shortened by increased hematocrit.
    • Red blood cell transfusions shortened bleeding time without altering other platelet function parameters.
    • Recombinant human erythropoietin effectively shortened bleeding time, correlating with a rise in hematocrit.

    Conclusions:

    • Hematocrit level is a critical determinant of bleeding time in anemic individuals.
    • Therapeutic strategies aimed at increasing hematocrit can mitigate bleeding risks.
    • Clinicians should consider diminished hematocrit as a factor in bleeding tendencies, especially in thrombocytopenic patients.